Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin, spironolactone and GLP-1 receptor agonist treatment in PCOS
ChiCTR-IIR-16008084Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Jan 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of metformin, spironolactone and exenatide in polycystic ovary syndrome (PCOS), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoints: insulin resistance, glucolipid metabolism index and 2 more. Started Jan 2015; status: recruiting.
02
Drugs
metforminspironolactoneexenatide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-IIR-16008084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16008084.